Skip to main content
spacbrain

Range Capital Acquisition Corp II

RNGT · Nasdaq · Biotech

No election on fileSearching

NO ACTION REQUIRED

Nothing required today

No redemption election is on file for this SPAC. A date appears here the day one is filed.

Nextcharter deadline6 October 2026

Not a redemption window — reaching it gives you no right to cash.

$10.27 cash floor$10.17
10 Aug20 closes · floor filed 30 Jun8 SeptThe shaded band is the distance between the price and the cash floor — what a redemption would pay you, or cost you, on the day.

SpacBrain’s read

Floor not confirmed

No redemption window has closed — but no dated redemption election is on file for this name either, so we cannot show you a date to act by.

What we do have: no window has closed, and the deadline we compute for it runs to 6 October 2026 — our arithmetic off the IPO date and the charter term, not a date any filing we hold states. That deadline is not itself a window you can redeem into. The full chain of evidence is under Evidence.

Change on the last daily close-0.1% day

That is $0.10 below the $10.27 of cash held per share as last filed — though the right to claim that cash is not confirmed on file. Against our ESTIMATE of what the trust holds today — ~$10.35, the filed figure carried forward at the T-bill — the same price is 1.7% below the cash. That estimate is our arithmetic, not a filing.


In plain terms

What it is
A $230M SPAC from Range Capital (Rotolo Tim), listed on Nasdaq in October 2025. Each unit put $10.00 into the shareholders' cash account at listing; it holds $10.27 a share today — interest earned on the account, plus any payments the sponsor made to extend the deadline, spread over the shares that never cashed out.
What it's doing now
It is still looking: no purchase has been announced. No filing we hold states the date it has to agree one by; our own estimate, from the IPO date and the charter term, is 6 October 2026. After that date it must ask shareholders for more time, or give the money back and close.
What you should know
We have no filed date on which you could claim the cash back, so we cannot tell you a day to act by. That is a gap in the public record, not a statement that the right has gone.

At a glance

Where it stands
Searching · next dated event 6 October 2026
charter deadline (our estimate) — not a date on which you can claim cash.
Merging with
No target announced — still searching.
Industry
Biotech
What it set out to buy: Biotech
Deal value
not stated in the filings we hold
Price vs cash floor
$10.17 vs $10.27
$0.10 below the last filed cash held for you; 1.7% below cash against our estimated ~$10.35
Cash left in trust
$236.2M
IPO
6 October 2025
$230M raised · 100.0% of each $10 unit into trust
Headquarters
44 MAIN STREET, COLD SPRING HARBOR, NY, 11724
registered in the Cayman Islands
Lead underwriter
BTIG, LLC
Key officers
Matina Alexander C (Director) · Rotolo Tim (Chief Executive Officer) · Lovett John (Director)
Listed securities
RNGT common · RNGTW warrant $0.33 · RNGT common $10.18 · RNGTU unit $10.65
Cash held per share$10.27

As last filed, 30 June 2026.

source: 10-Q acc 0001193125-26-349797

Cash per share today (estimate)~$10.35

Modelled, not filed: $10.27 filed 30 June 2026, compounded 72 days at the 3.95% 3-month T-bill (treasury.gov daily par yield curve). No tax drag, extension deposits or dissolution costs are modelled.

Price against the cash
vs last filed NAV
1.0%below cash
$10.27, 10-Q as of Jun 30, 2026, acc 0001193125-26-349797
vs estimated NAV today (our estimate)
1.7%below cash
~$10.35, accrued 72 days at 3.95%

Two denominators, one price. The filed figure is what a document says the trust held on its date; the estimate carries it forward at the T-bill for the days since, which is our arithmetic and not a filing.

Next date that matters6 October 2026

The date by which this SPAC must close a combination or return the trust. Reaching it is not itself a redemption window. What an outside date is →

Yield to redemption

No dated redemption window on file — no yield to compute.

We hold no redemption election for this SPAC. The only dated event on file is the charter deadline on Oct 6, 2026, which pays a holder nothing — so no yield can be measured to it. An unsourced date would make the yield look filed when it is not.


What is protecting this price

The reasoning behind the verdict above, in the order the filings establish it.

  1. No dated redemption election is on file for this name. That is an absence in the record, not proof that the right has gone — but it does mean this page cannot tell you a day to act by.
  2. Cash held in trust is $10.27 per share as last filed. That is the figure a redemption pays out at, plus whatever interest the trust earns between the filing and the window.
  3. The charter runs to a date no filing we hold states; from the IPO date and the charter term we estimate 6 October 2026. Whenever it falls, if no deal closes by then the trust is returned to holders — a floor of a different kind: it pays out, but you do not choose when, and this one you should read out of the prospectus yourself.

What has happened, and what is coming

1 dated milestone

Every dated step from the day it listed to the next date you may have to act on. Where you have to do something, the day your broker needs the instruction is marked too.

  1. 6 October 2025IPOpassed

    $230M raised into trust


The score

deterministic, from filed fields

One number for the shape of the bet: how much upside you are getting per unit of downside. It is arithmetic over filed fields, not a rating and not advice — and it is the same number this SPAC carries on the leaderboard, the screener and the deal list, because all four read one engine.

Asymmetric return scoreThe tick is 57, the median of the 292 names scored.

1.0% below the last filed trust — floor not confirmed — no redemption election on file

The blend is trust discount (40 points), deal stage (30), sponsor track record (18) and time to catalyst (12). Every input is a real sourced field; where one is missing, confidence drops rather than a number being invented.

See where RNGT ranks, and how the score is built


The company

from SEC filings
Read the full profile

Range Capital's second SPAC: $230 million raised on Nasdaq in October 2025, with no target yet per its Q2 2026 10-Q. Its 23 million units at $10.00 are fully backed by trust; sister vehicle Range Capital Acquisition (RANG) is tracked separately.


Material findings

from the full read of every filing

Every document this company files gets read whole — body and exhibits. These are the ones the read flagged as material, newest first, each citing its filing.

  • The trust is growing modestly, but the burn rate on cash ($306,098 spent in six months) combined with the going concern warning signals that the SPAC must find a deal soon or risk liquidation. The absence of any substantive target discussions (as stated by management) contrasts with the ticking 24-month deadline (October 2027). The sponsor's willingness to advance only $15,065 suggests limited external support for operations. The trust per-share value of $10.27 is above the IPO price, providing a modest premium for redeeming shareholders. The material risk is whether the SPAC can consummate a deal within its remaining window given the cash constraints.

  • This is the SPAC's first 10-K and confirms it is searching with a 24-month deadline (October 2027). Trust per-share value is $10.09, slightly above the $10.00 IPO price. Key risk: no target has been identified, and the SPAC competes with a sister SPAC (Range I, which IPO'd earlier). If a target is announced, the trust value is sufficient to provide roughly $10.00 per share in redemption plus a small interest premium.

  • The filing group asserts a combined beneficial interest meeting the Section 13(d) reporting threshold, though the precise magnitude remains concealed in this administrative wrapper. Authorized exclusively by attorney-in-fact Hayley Stein for Administrative Manager David J. Snyderman, the document conveys no intelligence on customer concentration, revenue streams, market size estimates, strategic pivots, intellectual property, commercial partnerships, active litigation, or executive compensation. SPAC investors tracking RNGT obtain confirmation of cooperative institutional reporting alignment but receive no quantifiable leverage for deadline management or capital preservation assessments.

  • This filing is material as it confirms the SPAC is now public with a $230M trust ($10.27 per share as noted in the prompt, consistent with the $10.00 per unit plus initial trust earnings) and has started the 24-month clock to find a deal. Key details for investors: the founder shares are no longer subject to forfeiture, and the lock-up on founder shares lifts at $12.00 for 20 out of 30 trading days. The sponsor indemnification clause is included but flagged as likely unenforceable since the sponsor's only assets are the SPAC's securities.

  • This filing establishes the finalized trust balance, confirms the 24-month liquidation deadline, and details the sponsor-induced dilution mechanics and fixed monthly burn rate before target selection begins. Because the registrant confirms zero active merger talks, the capitalization structure, trust maturity timeline, and underwriter fee tranches become the primary variables for investors modeling extension scenarios or redemption thresholds.

  • This filing establishes the baseline trust value (~$10.27 per public share based on the $10.00 IPO price plus any accrued interest) and the deadline for a business combination. Investors can now track the trust value, redemption deadlines, and sponsor conduct (lock-up on founder shares: one year post-business combination or $12.00 price trigger; private placement lock-up: 30 days post-business combination). The absence of a target means the SPAC is in its searching phase. The trust agreement requires joint instructions from the company and the underwriter for any disbursement, providing additional investor protection.

Show 7 more material filings
  • Per the Form 4 data, the CEO’s direct market acquisition contracts the publicly held float while the SPAC remains in SEARCHING status, which historically influences participant behavior near any upcoming redemption cutoff or conversion date. The submission contains no assertions about target-customer relationships, revenue trajectories, addressable market sizing, proprietary technology, channel partnerships, contingent liabilities, or leadership transitions beyond confirming the existing executive roster. Because the purchase was sourced from open-market liquidity rather than a private PIPE or warrant exercise, it does not formally alter the stated trust value or trigger any automatic timeline extension, but it does register sponsor-level capital allocation that may serve as a market signal ahead of future deal milestones.

  • According to the filing, the nominal $0.003 per share founder share purchase price creates material immediate dilution, which may increase further due to anti-dilution conversion rights that can yield more than one Class A ordinary share per founder share upon business combination completion. The document outlines a generalist acquisition strategy targeting capital-constrained sectors like Energy, Nuclear Energy, Fertility, and Defense Tech, focusing on North American entities with enterprise values of $500 million or more.

  • This is the operative IPO disclosure for a searching SPAC, establishing the trust amount, redemption mechanics, 24-month completion deadline, warrant terms, sponsor economics, dilution, and conflicts with Range Capital Acquisition Corp. It gives investors the baseline for future redemption deadlines, extension votes, and any later business-combination filings.

  • The explicit confirmation that redemption eligibility survives regardless of extension voting creates a definitive liquidity backstop during any proxy campaign to prolong the SEARCHING phase. Identifying the affirmative vote threshold establishes the precise consent mechanic that must trigger before trust capital becomes deployable. Confirming identical warrant economics for insiders and the public removes governance risk tied to differential exercise timing or redemption call exploitation.

  • Sets the baseline for redemption mechanics, trust value, and timeline. The trust is stated at $10.00 per share initially. Investors should note the 24-month deadline, the ability to extend with shareholder approval (with redemption rights for public shareholders), and the structure of redemption rights (per share = aggregate trust amount divided by outstanding public shares, less taxes). The sponsor acquired founder shares at a nominal price, creating potential dilution and conflict of interest. The filing also notes that the management team has a prior SPAC (Range Capital Acquisition Corp I, IPO December 2024) which may create competition for targets. There is a going concern qualification in the financial statements as of June 30, 2025 (cash $9,280, working capital deficit $39,597).

  • This filing reveals regulatory scrutiny of sponsor-economic alignment, conflict structures, and accounting treatment that dictate deal execution and trust preservation.

  • The document precisely maps the economic architecture, dilution vectors, and fiduciary boundaries that will govern public shareholder exits and sponsor incentives. The combination of unlimited extension options, the 15% redemption ceiling, and sponsor-controlled governance (including waived redemption rights for founders/private units and alignment with Range I’s timeline through June 2026) shifts downside protection toward the sponsor and creates potential misalignment when evaluating overlapping deals.


Filings

live EDGAR feed

Everything this company has filed with the SEC recently, newest first, each with a plain summary of what changed and why it matters.

  • What changed: Quarterly report (Form 10-Q) for the period ended June 30, 2026. Trust value per share increased from $10.09 at December 31, 2025 to $10.27 at June 30, 2026, reflecting $4,145,438 of interest earned on trust investments during the six-month period. Cash decreased from $1,122,608 to $816,510, and working capital fell to $790,234. The company reported net income of $3,778,200 for the six-month period. Management disclosed substantial doubt about going concern due to insufficient funds to sustain operations for the next year. No Business Combination target has been selected, and no substantive discussions have occurred. The sponsor advanced $15,065 to cover operating expenses during the quarter. No insider trading arrangements were adopted or terminated by directors or officers. Why it matters: The trust is growing modestly, but the burn rate on cash ($306,098 spent in six months) combined with the going concern warning signals that the SPAC must find a deal soon or risk liquidation. The absence of any substantive target discussions (as stated by management) contrasts with the ticking 24-month deadline (October 2027). The sponsor's willingness to advance only $15,065 suggests limited external support for operations. The trust per-share value of $10.27 is above the IPO price, providing a modest premium for redeeming shareholders. The material risk is whether the SPAC can consummate a deal within its remaining window given the cash constraints.

    What changed vs 2026-05-15trust $234.2M → $236.2M +1%
    trust account, going-concern doubt, redeemable shares1 moved · 2 with no prior record of ours
    Trust account
    $234.2M$236.2M

    SpacBrain reads this as $2,086,234 was added to the trust between the two filings.

    The clause “1,841 1,208,059 Long-term prepaid insurance 17,508 52,523 Marketable securities held in Trust Account 236,249,983 232,104,545 Total Assets $ 237,199,332 $ 233,365,127 Liabilities, Class A Ordinary Shares Subject to Possible Redemption and”…

    Going-concern doubt
    stated · unchanged

    The clause …“its acquisition plans. Management has determined the liquidity issue raises substantial doubt about the Company’s ability to continue as a going concern for one year from the date the unaudited condensed financial statements are”…

    Redeemable shares
    23.0M · unchanged

    The clause …“490,000,000 shares authorized; 660,000 issued and outstanding (excluding 23,000,000 shares subject to possible redemption) as of June 30, 2026 and December 31, 2025 66 66 Class B ordinary shares, $ 0.0001 par value; 10,000,000”…

    Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.

  • What changed: Quarterly report (Form 10-Q) for the period ended March 31, 2026, filed by Range Capital Acquisition Corp II, a blank-check company in search of a business combination. No new business combination target or definitive agreement. The company reported net income of $1,843,929 for the quarter, primarily from interest on trust account. Trust per share increased from $10.09 to $10.18. Cash decreased to $922,610. Management reiterates substantial doubt about going concern due to insufficient working capital to sustain operations for one year. No changes to redemption mechanics, extension deadlines, or sponsor conduct. Why it matters: Routine compliance filing with no material developments. The trust value per share is growing slightly, but the company has no target and is burning cash on operations. The going concern disclosure highlights the risk of liquidation if no deal is completed within the 24-month window (by October 2027). No new information for redemption calendar or deal progress.

    What changed vs 2025-11-07going concern APPEARED
    going-concern doubt, trust account, redeemable shares +11 moved · 3 with no prior record of ours
    Going-concern doubt
    not statedstated

    SpacBrain reads this as the substantial-doubt sentence is in this filing and not in the previous one.

    The clause …“its acquisition plans. Management has determined the liquidity issue raises substantial doubt about the Company’s ability to continue as a going concern for one year from the date the unaudited condensed financial statements are”…

    Trust account
    not previously extracted$234.2M

    The clause “1,591 1,208,059 Long-term prepaid insurance 35,016 52,523 Marketable securities held in Trust Account 234,163,749 232,104,545 Total Assets $ 235,260,356 $ 233,365,127 Liabilities, Class A Ordinary Shares Subject to Possible Redemption and”…

    Redeemable shares
    not previously extracted23.0M

    The clause …“490,000,000 shares authorized; 660,000 issued and outstanding (excluding 23,000,000 shares subject to possible redemption) as of March 31, 2026 and December 31, 2025 66 66 Class B ordinary shares, $ 0.0001 par value; 10,000,000”…

    Sponsor loans outstanding
    $207Knot matched in this filing

    Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.

  • What changed: Annual report on Form 10-K for a newly-public SPAC covering its first fiscal year (inception through December 31, 2025), including audited financial statements, description of the IPO, and boilerplate risk factors. No deal-related changes. The SPAC completed its IPO on October 6, 2025, raising $230M (23M units, including 3M from full over-allotment exercise), with an additional $6.6M from a private placement. Trust holds $232,104,545 ($10.09 per share, including interest). The 1,000,000 founder shares subject to forfeiture were released upon over-allotment exercise. The company has not announced a target or definitive agreement. Insider trading policy and clawback policy were adopted. As of December 31, 2025, cash outside trust was $1,122,608. Why it matters: This is the SPAC's first 10-K and confirms it is searching with a 24-month deadline (October 2027). Trust per-share value is $10.09, slightly above the $10.00 IPO price. Key risk: no target has been identified, and the SPAC competes with a sister SPAC (Range I, which IPO'd earlier). If a target is announced, the trust value is sufficient to provide roughly $10.00 per share in redemption plus a small interest premium.

  • What changed: A joint filing agreement accompanying a Schedule 13G beneficial ownership report. The attached filing does not adjust RNGT’s redemption deadline, trust composition, extension mechanics, acquisition timeline, or sponsor governance. It records an administrative acknowledgment, executed by Shane Cullinane (Chief Operating Officer), Allyson Hanlon (Deputy General Counsel), Ben Levine, and Stefan Renold on behalf of LMR Partners LLP, LMR PARTNERS Ltd, LMR Partners LLC, LMR Partners AG, LMR PARTNERS (DIFC) Ltd, and LMR Partners (Ireland) Limited, that all subsequent Schedule 13G amendments for these parties will be submitted jointly, with each entity retaining independent liability for its own disclosed position. Why it matters: Investors tracking redemption windows or deal progression will find no operational triggers, valuation adjustments, or business-combination disclosures herein. The filing merely consolidates future regulatory reporting for the LMR network, confirming continued aggregate beneficial ownership subject to the five-percent-plus threshold while adding no new data regarding target selection, financing milestones, or shareholder voting timelines.

  • What changed: A Schedule 13G joint filing agreement (Exhibit 99.1) filed on February 17, 2026, by Magnetar Financial LLC, Magnetar Capital Partners LP, Supernova Management LLC, and David J. Snyderman, declaring their mutual consent to submit a single beneficial ownership report for Range Capital Acquisition Corp II shares as of December 31, 2025 pursuant to Rule 13d-1(k) under the Securities Exchange Act of 1934. The provided text comprises only the authorization signature block; it omits the primary Schedule 13G body that would specify aggregate share counts, acquisition dates, cost basis, or ownership percentages. Consequently, the document reports zero modifications to RNGT’s redemption deadline, trust account mechanics, extension vote schedule, target discovery progress, or sponsor conduct. No transactional or governance triggers are activated by this excerpt. Why it matters: The filing group asserts a combined beneficial interest meeting the Section 13(d) reporting threshold, though the precise magnitude remains concealed in this administrative wrapper. Authorized exclusively by attorney-in-fact Hayley Stein for Administrative Manager David J. Snyderman, the document conveys no intelligence on customer concentration, revenue streams, market size estimates, strategic pivots, intellectual property, commercial partnerships, active litigation, or executive compensation. SPAC investors tracking RNGT obtain confirmation of cooperative institutional reporting alignment but receive no quantifiable leverage for deadline management or capital preservation assessments.

Show the other 10 filings
  • What changed: This document is a Schedule 13G/A beneficial ownership amendment accompanied by Exhibit A, a Joint Filing Agreement executed on February 10, 2026, that consolidates the Securities and Exchange Commission reporting obligations of Linden Capital L.P., Linden GP LLC, Linden Advisors LP, and Siu Min Wong for their aggregate holdings in Range Capital Acquisition Corp II under Rule 13d-1(k). The filing introduces no alterations to redemption deadlines, trust distribution mechanics, extension procedures, or business combination timelines. It merely extends the existing joint reporting framework to any future Schedule 13G amendments relative to the baseline statement dated December 31, 2025. The filing contains no announcements regarding sponsorship conduct, voting threshold adjustments, or procedural modifications to shareholder redemptions. Why it matters: Beyond confirming administrative continuity through the joint filing arrangement, the document contains no substantive claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. The only external references cited are a Power of Attorney dated June 10, 2019 and a prior Schedule 13G filed June 19, 2019 concerning Haymaker Acquisition Corp II, both invoked to legally authorize Saul Ahn to sign on behalf of the listed entities and individual. Attributed entirely to the executing Linden representatives, the filing serves purely as regulatory housekeeping and is not material to the acquisition pursuit, trust valuation, or holder economics.

  • What changed: Schedule 13G Joint Filing Agreement (Exhibit A) designating Linden Capital L.P., Linden GP LLC, Linden Advisors LP, and Siu Min Wong as co-filed participants for a single beneficial ownership report regarding Range Capital Acquisition Corp II (RNGT) shares, executed by Saul Ahn on November 25, 2025. The filing modifies only the disclosure architecture for existing affiliates by consolidating their Section 13(g) reporting into one submission under Rule 13d-1(k). It does not introduce revised redemption deadlines, trust account adjustments, extension ballots, business combination milestones, or sponsor governance changes. The agreement contains no data on customer acquisition, revenue recognition, total addressable market sizing, product roadmaps, intellectual property, vendor agreements, legal proceedings, or leadership transitions. Why it matters: The joint filing confirms that four affiliated entities share a single reporting funnel, with Saul Ahn exercising signing authority via a power of attorney dated June 10, 2019. The explicit cross-reference to a prior Statement on Schedule 13G filed on June 19, 2019, for Haymaker Acquisition Corp II documents a continuity of compliance infrastructure rather than a new capital event. While the agreement leaves RNGT’s search window, cash position, and shareholder voting mechanics untouched, it provides a transparent registry of which principals are bundled for future amendment tracking, affiliation threshold monitoring, and block trade disclosure. Because the document offers no operational or financing update, investors requiring visibility into RNGT’s target pipeline, trust yield fluctuations, or extension triggers must consult subsequent Registration Act filings, DEF 14A proxies, or voluntary management announcements.

  • What changed: Form 8-K current report attaching a press release announcing the election to separately trade IPO units into component securities. The Company announced, via a press release dated November 19, 2025, that unit holders may elect to split their RNGTU units into individually traded Class A ordinary shares (RNGT) and warrants (RNGTW) commencing on or about November 24, 2025. Separation requires brokers to contact transfer agent Continental Stock Transfer & Trust Company. The filing confirms the units consist of one Class A ordinary share with a par value of $0.0001 per share and one-half of one redeemable warrant, with each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50. The governing registration statement became effective on September 30, 2025. This procedural update carries zero impact on the company’s redemption deadlines, trust account administration, extension voting schedule, or business combination negotiation progress. Why it matters: Because the announcement strictly governs secondary market listing mechanics rather than corporate action milestones, investors tracking capital deployment should note it does not trigger early redemptions, require sponsor extensions, or indicate deal term sheet execution. The press release explicitly states the registrant remains in its search phase and that 'No assurance can be given that the Company will ultimately complete an initial business combination,' adding further distance between this filing and any merger resolution. Executive leadership was represented solely by Chief Executive Officer Tim Rotolo, who signed the report and listed contact details at www.rangecapspac.com and tjr@rangecapspac.com. Prospectus copies remain available through BTIG, LLC at 65 East 55 Street, New York, NY 10022. Until a target is identified, the trust balance and deadline calendar remain operationally frozen per prior charter provisions.

  • What changed: A Form 10-Q (Quarterly Report) for Range Capital Acquisition Corp II, a blank-check SPAC incorporated in May 2025 and still searching for a target. This is the first Quarterly Report filed since inception. The key development is the closing of the Initial Public Offering on October 6, 2025. The SPAC sold 23,000,000 Units (including full exercise of the 3,000,000-unit over-allotment) at $10.00 per Unit, generating $230,000,000 in gross proceeds, all deposited into the trust account. Simultaneously, the company completed a concurrent private placement of 660,000 units to the sponsor and BTIG, LLC for an additional $6,600,000. Non-managing investors purchased 350,000 of the private placement units. The sponsor transferred 25,000 founder shares to the CFO. The 1,000,000 founder shares previously subject to forfeiture are now released. Total transaction costs were $13,232,284. The financials as of Sept 30, 2025, show no operations, a cash balance of $9,280, and a shareholders' deficit of $(24,800). Why it matters: This filing is material as it confirms the SPAC is now public with a $230M trust ($10.27 per share as noted in the prompt, consistent with the $10.00 per unit plus initial trust earnings) and has started the 24-month clock to find a deal. Key details for investors: the founder shares are no longer subject to forfeiture, and the lock-up on founder shares lifts at $12.00 for 20 out of 30 trading days. The sponsor indemnification clause is included but flagged as likely unenforceable since the sponsor's only assets are the SPAC's securities.

  • What changed: A Form 8-K Current Report and accompanying audited balance sheet and notes disclosing the consummation of Range Capital Acquisition Corp II’s initial public offering and private placements on October 6, 2025. Document identification: This filing reports the October 6, 2025 closing of the Company’s IPO. Mechanics: According to the registrant, $230,000,000 ($10.00 per Unit) from net proceeds was deposited into a trust account administered by Continental Stock Transfer & Trust Company. The Company defines a Completion Window of 24 months from the IPO closing; if unmet, the board may approve an earlier date, otherwise shares will be redeemed within ten business days at a per-share price equal to the Trust Account balance plus interest, less taxes and up to $100,000 for dissolution costs. Regarding sponsor conduct and structuring, the filing states Range Capital Acquisition Sponsor II, LLC acquired 430,000 Private Placement Units and BTIG, LLC acquired 230,000 Private Placement Units at $10.00 each for $6,600,000 total proceeds. Transaction costs are listed as $13,232,284, comprising $4,600,000 in cash underwriting fees and $8,050,000 in deferred underwriting fees payable only upon a business combination. The Company notes non-managing investors indirectly purchased 350,000 Private Placement Units through the Sponsor, resulting in a recorded equity charge of $14,364,000 based on a third-party valuation of $5.13 per share for approximately 2,800,000 founder shares. An affiliated administrative services agreement mandates monthly payments of $20,000. Other substance: The Company explicitly states it has not selected a target business and has conducted no substantive discussions regarding an initial business combination. There are 11,830,000 Public Warrants and 330,000 Private Placement Warrants outstanding, each exercisable at $11.50 per share. The Company may instruct the trustee to hold trust funds in cash or interest-bearing deposits to mitigate Investment Company Act classification risks. Why it matters: This filing establishes the finalized trust balance, confirms the 24-month liquidation deadline, and details the sponsor-induced dilution mechanics and fixed monthly burn rate before target selection begins. Because the registrant confirms zero active merger talks, the capitalization structure, trust maturity timeline, and underwriter fee tranches become the primary variables for investors modeling extension scenarios or redemption thresholds.

  • What changed: A Schedule 13D beneficial ownership report, classified as a routine SEC compliance exhibit mandated by Section 13(d) of the Securities Exchange Act of 1934. Regarding the tracked mechanics, the provided excerpt discloses no alteration to the redemption deadline, no update to the trust-per-share balance, no extension vote schedule, no target identification progress, and no statement regarding sponsor conduct or capital contribution. The filing text contains only the SEC identifier and a system note confirming the structured holder table is absent, leaving the SPAC’s operational timeline and investor exit parameters unchanged. Why it matters: Schedule 13D filings normally require disclosure of transactions exceeding five percent ownership, including the source of funds, identity of the reporting person, and stated purpose—information that often signals activist positioning, pre-combination accumulation, or negotiated lock-ups. Because the supplied XML variant strips the holder table and narrative exhibits, no factual assertions about customers, revenue projections, market size, technology roadmap, partnership arrangements, pending litigation, or executive transitions are present for evaluation. Until the complete filing or a definitive merger agreement surfaces, the document provides no actionable signal on deal progress or trust preservation, and the SEARCHING status remains unadjusted.

  • What changed: A Form 4 insider ownership report. According to the filing, Range Capital Acquisition Sponsor II, LLC executed an open-market purchase on 2025-10-06, acquiring 430,000 shares. The submission states that following this transaction, the sponsor owns 430,000 shares total and self-classifies as a 10% owner. This transaction reflects sponsor conduct and does not alter redemption deadlines, trust account mechanics, extension procedures, or business combination timelines, as the issuer remains in a SEARCHING status. No amendments to shareholder approval thresholds or mandatory investment provisions are disclosed. Why it matters: The filing contains no additional substantive disclosures regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Because the acquisition occurred on the open market, it constitutes a secondary market transaction that neither affects public shareholder redemption windows nor impacts trust account preservation. The sole operational update is the documented increase in sponsor shareholding.

  • What changed: Form 8-K filed to report the consummation of Range Capital Acquisition Corp II's initial public offering, including the entry into underwriting, warrant, trust, registration rights, and other ancillary agreements, the appointment of directors, adoption of amended charter, and the placement of proceeds in trust. The SPAC closed its IPO of 23,000,000 units at $10.00 per unit (including full exercise of the 3,000,000-unit over-allotment), generating $230,000,000 in gross proceeds deposited into the trust account. Simultaneously, 660,000 private placement units were sold to the sponsor (430,000) and the underwriter (230,000) for $6,600,000. Directors James Grigor, Alexander Matina, and John Lovett were appointed to the board. The amended and restated memorandum and articles of association were adopted, authorizing 490M Class A, 10M Class B, and 100M preference shares. The trust account will be held for public shareholders with a 24-month completion window from the closing date (October 6, 2025). No business combination target has been identified. Why it matters: This filing establishes the baseline trust value (~$10.27 per public share based on the $10.00 IPO price plus any accrued interest) and the deadline for a business combination. Investors can now track the trust value, redemption deadlines, and sponsor conduct (lock-up on founder shares: one year post-business combination or $12.00 price trigger; private placement lock-up: 30 days post-business combination). The absence of a target means the SPAC is in its searching phase. The trust agreement requires joint instructions from the company and the underwriter for any disbursement, providing additional investor protection.

  • What changed: Form 4 — Statement of Changes in Beneficial Ownership, a routine compliance exhibit tracking insider security transactions. According to the filing, Director and Chief Executive Officer Tim Rotolo executed an open-market purchase of 430,000 shares on 2025-10-06, leaving him with exactly 430,000 shares post-transaction. The report lists him as a 10% owner. No modifications to redemption deadlines, trust distribution mechanics, extension triggers, or active business combination negotiations are disclosed. Why it matters: Per the Form 4 data, the CEO’s direct market acquisition contracts the publicly held float while the SPAC remains in SEARCHING status, which historically influences participant behavior near any upcoming redemption cutoff or conversion date. The submission contains no assertions about target-customer relationships, revenue trajectories, addressable market sizing, proprietary technology, channel partnerships, contingent liabilities, or leadership transitions beyond confirming the existing executive roster. Because the purchase was sourced from open-market liquidity rather than a private PIPE or warrant exercise, it does not formally alter the stated trust value or trigger any automatic timeline extension, but it does register sponsor-level capital allocation that may serve as a market signal ahead of future deal milestones.

  • What changed: A final registration statement supplement (Form 424B4) for the initial public offering of 20,000,000 units by Range Capital Acquisition Corp II. According to the filing, the company must consummate an initial business combination within 24 months from the offering’s closing date, with no statutory limit on extensions subject to shareholder approval, though management states it does not expect to exceed a 36-month total period. Why it matters: According to the filing, the nominal $0.003 per share founder share purchase price creates material immediate dilution, which may increase further due to anti-dilution conversion rights that can yield more than one Class A ordinary share per founder share upon business combination completion. The document outlines a generalist acquisition strategy targeting capital-constrained sectors like Energy, Nuclear Energy, Fertility, and Defense Tech, focusing on North American entities with enterprise values of $500 million or more.


The record

The reference detail — how the shares were structured at listing, how thinly they trade, and where the company is registered.

Show the reference detail

Unit structure

Cash in trust at IPO$10.00

That was the figure at listing. It is $10.27 a share today — interest on the account, plus any sponsor payments made to extend the deadline, spread over the shares that never cashed out. Unit: U = S + W/2 · 100.0% of the $10 unit

from 424B4 0001193125-25-230644

Unit quote (RNGTU)$10.65

as of 10 September 2026

Warrant quote (RNGTW)$0.33

as of 3 September 2026

Trading & liquidity

Average daily volume (20d)11K
Average daily $ volume$112K

Thin book — limit orders only; a position can be hard to exit outside a redemption window.

Range over the bars held$10.13 – $10.18
Total cash in trust$236.2M

Company profile

Industry (SIC)Blank Checks (6770)
Registered inthe Cayman Islands
Exchange · CIKNasdaq · 0002078653

All filings on EDGARopens on sec.gov in a new tab

Directors & officers


Institutional holders

from SC 13G/13D

Funds that have declared a stake above 5%. Heavy ownership by arbitrage funds usually means heavy cash-outs at the next vote.

Show the declared stakes

4 filers with a stake on file · 4 re-affirmed in the last 12 months. A stake with no amendment since is the filer’s last word on it, not proof it is still held — and percentages filed in different years are percentages of different floats, because this vehicle’s share count collapses at every redemption.

One line per filer, not per reporting person: a joint schedule names the management company, its funds and often the individual who controls them, and all of them report the same shares. Click a name for that filer’s whole footprint across every SPAC it has declared a stake in.


Sources on file

harvested pages, kept in full

Every public page we have read about this company, stored in full so a source can never go missing.

Show the sources

39 full SEC filing texts archived — searchable, never lost.


Cash in trust over time

XBRL, per filing

How much cash has stood behind each share at each filing date.

Show the filed values
  • 30 June 2026$10.27
  • 30 June 2026

In plain English

tap a term to open it

Every piece of jargon this page could have used, and what it actually means.

Open the plain-English guide
No floor / floorlessthe cash guarantee is gone — the price is unprotected

A SPAC's downside protection is not the cash in trust; it is your right to demand that cash. Once the redemption window closes, the cash stays with the company and the share can trade anywhere.

Redemption deadlinethe last day to hand shares back for cash

Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.

Broker action datethe day your broker needs the instruction — earlier than the official date

Brokers batch redemption instructions to the transfer agent, so the practical cutoff is roughly two business days before the published deadline. This is the date that actually costs people the floor.

Cash in trust / trust per sharethe cash the company is holding for each public share

Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.

Trust discountbuying below the cash held for you

Only meaningful while a redemption right exists. On a floorless name the same arithmetic is not a discount, it is the market pricing distress, and this product will not call it a yield.

Dilutionhow much of the company new shares take from you

Sponsor promote, PIPE shares, warrants and rights all issue stock that did not pay $10 for it. The headline deal value is before that; the effective value is after.

Pro-forma equitywhat the company is valued at once the deal closes

The combined company's equity value assuming the announced terms and the redemptions that have actually happened.

ARShow much upside you get per unit of downside

SpacBrain's asymmetric-return score. It is deterministic — the same inputs always produce the same number — and it is capped, not zeroed, when the floor is gone.

De-SPACthe day the SPAC becomes the real company

The shares stop being a claim on a pot of cash and start being equity in an operating business. Roughly 80% of recent de-SPACs traded below $10 within a year.

Outside datethe contractual long-stop for closing the deal

A deadline between the SPAC and its target, not between the SPAC and you. It confers no right to cash, which is exactly why it must never be counted as a redemption window.

Accession numberthe SEC's unique id for one filing

Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.

Accreted NAV (estimate)the last filed cash figure, plus the interest it should have earned since

A model, not a filing: last filed value compounded at the 3-month T-bill for the days elapsed. Always shown in italic with the word estimate, and never printed beside a filed number without it.


Ask the brain

from its filings
Data provenance & audit trail3 internal entries

Written by SpacBrain’s data agents whenever a figure is captured, corrected or flagged, and kept verbatim so every number on this page can be traced back to the filing that states it. This is a running log, not the current record: an early entry may be superseded by a later correction — the panels above always hold the current values.

RNGT — company record
UNIVERSE2026-08-14

Admitted from orphan-filing sweep. Blank check: SIC 6770 (EDGAR). Ticker RNGT (RNGTU/RNGTW), Nasdaq, from Q2-2026 10-Q cover (filed 2026-08-14, primary d162152d10q.htm). IPO 2025-10-06: 23,000,000 units, gross $230,000,000; trust $230,000,000 = $10.00/unit (10-Q). No 425/S-4 -> SEARCHING. Sibling of tracked Range Capital (RANG, cik 0002035644). Sponsor not cleanly stated -> null. Missing for downstream: quotes, deadline, sponsor entity, people, summaries.

SECURITY-TERMS-MINED2026-08-19

warrantStrike=11.5, warrantCallPrice=18, unitSeparationDays=52 from the definitive prospectus (0001193125-25-230644). NOT FILLED: rightShareRatio — no stated candidate

SPONSOR-ID2026-08-14

sponsor "Range Capital Acquisition Sponsor II, LLC" (SEC CIK 0002089986) sourced from Form 3 reportingOwner (10% owner) acc 0001193125-25-228873.